Wishart, D. S. et al. HMDB 5.0: The Human Metabolome Database for 2022. Nucleic Acids Res. 50, D622–D631 (2022).
Babu, M. & Snyder, M. Multi-omics profiling for health. Mol. Cell Proteomics 22, 100561 (2023).
Li, Y. et al. Healthy lifestyle and life expectancy free of cancer, cardiovascular disease, and type 2 diabetes: Prospective cohort study. BMJ 368, l6669 (2020).
Li, Y. et al. Impact of healthy lifestyle factors on life expectancies in the US population. Circulation 138, 345–355 (2018).
Nyberg, S. T. et al. Association of healthy lifestyle with years lived without major chronic diseases. JAMA Intern. Med. 180, 760–768 (2020).
Carrard, J. et al. The metabolic signature of cardiorespiratory fitness: A systematic review. Sports Med. 52, 527–546 (2022).
Castro, A. et al. Understanding the relationship between intrinsic cardiorespiratory fitness and serum and skeletal muscle metabolomics profile. J. Proteome Res. 20, 2397–2409 (2021).
Contrepois, K. et al. Molecular choreography of acute exercise. Cell 181, 1112-1130.e16 (2020).
Kistner, S. et al. Sex-specific relationship between the cardiorespiratory fitness and plasma metabolite patterns in healthy humans-results of the KarMeN study. Metabolites 11, 463 (2021).
Weiss, A. et al. Sustained endurance training leads to metabolomic adaptation. Metabolites 12, 658 (2022).
Noerman, S. & Landberg, R. Blood metabolite profiles linking dietary patterns with health-toward precision nutrition. J. Intern. Med. 293, 408–432 (2023).
Lépine, G. et al. A scoping review: Metabolomics signatures associated with animal and plant protein intake and their potential relation with cardiometabolic risk. Adv. Nutr. 12, 2112–2131 (2021).
Rafiq, T. et al. Nutritional metabolomics and the classification of dietary biomarker candidates: A critical review. Adv. Nutr. 12, 2333–2357 (2021).
Andraos, S. et al. Characterizing patterns of dietary exposure using metabolomic profiles of human biospecimens: A systematic review. Nutr. Rev. 80, 699–708 (2022).
Kim, H. & Rebholz, C. M. Metabolomic biomarkers of healthy dietary patterns and cardiovascular outcomes. Curr. Atheroscler. Rep. 23, 26 (2021).
LeVatte, M., Keshteli, A. H., Zarei, P. & Wishart, D. S. Applications of metabolomics to precision nutrition. Lifestyle Genom. 15, 1–9 (2022).
Giesbertz, P. et al. Age-related metabolite profiles and their relation to clinical outcomes in young adults, middle-aged individuals, and older people. FASEB J. 37, e22968 (2023).
Cirulli, E. T. et al. Profound perturbation of the metabolome in obesity is associated with health risk. Cell Metab. 29, 488-500.e2 (2019).
Auguet, T. et al. LC/MS-based untargeted metabolomics analysis in women with morbid obesity and associated type 2 diabetes mellitus. Int. J. Mol. Sci. 24, 7761 (2023).
Ho, J. E. et al. Metabolomic profiles of body mass index in the Framingham heart study reveal distinct cardiometabolic phenotypes. PLoS ONE 11, e0148361 (2016).
Watanabe, K. et al. Multiomic signatures of body mass index identify heterogeneous health phenotypes and responses to a lifestyle intervention. Nat. Med. 29, 996–1008 (2023).
Carayol, M. et al. Blood metabolic signatures of body mass index: A targeted metabolomics study in the EPIC cohort. J. Proteome Res. 16, 3137–3146 (2017).
Bellot, P. E. N. R. et al. are phosphatidylcholine and lysophosphatidylcholine body levels potentially reliable biomarkers in obesity? A review of human studies. Mol. Nutr. Food Res. 67, e2200568 (2023).
Navarro, S. L. et al. Demographic, health and lifestyle factors associated with the metabolome in older women. Metabolites 13, 514 (2023).
Lu, Q. et al. Healthy lifestyle, plasma metabolites, and risk of cardiovascular disease among individuals with diabetes. Atherosclerosis 367, 48–55 (2023).
Kaspy, M. S. et al. Metabolomic profile of combined healthy lifestyle behaviours in humans: A systematic review. Proteomics 22, e2100388 (2022).
Palau-Rodriguez, M. et al. Effects of a long-term lifestyle intervention on metabolically healthy women with obesity: Metabolite profiles according to weight loss response. Clin. Nutr. 39, 215–224 (2020).
Dunn, W. B. et al. Systems level studies of mammalian metabolomes: The roles of mass spectrometry and nuclear magnetic resonance spectroscopy. Chem. Soc. Rev. 40, 387–426 (2011).
Wishart, D. S. Metabolomics for investigating physiological and pathophysiological processes. Physiol. Rev. 99, 1819–1875 (2019).
Nieman, D. C. et al. Healthy lifestyle linked to innate immunity and lipoprotein metabolism: A cross-sectional comparison using untargeted proteomics. Sci. Rep. 13, 16728 (2023).
Li, Y.-Y. et al. Untargeted metabolomics: Biochemical perturbations in Golestan cohort study opium users inform intervention strategies. Front. Nutr. 7, 584585 (2020).
Ghanbari, R. et al. Metabolomics reveals biomarkers of opioid use disorder. Transl. Psychiatry 11, 103 (2021).
Lynch, D. H. et al. Baseline serum biomarkers predict response to a weight loss intervention in older adults with obesity: A pilot study. Metabolites 13, 853 (2023).
Sun, J. & Xia, Y. Pretreating and normalizing metabolomics data for statistical analysis. Genes Dis. 11(3), 100979. https://doi.org/10.1016/j.gendis.2023.04.018 (2023).
Chan, E. C., Pasikanti, K. K. & Nicholson, J. K. Global urinary metabolic profiling procedures using gas chromatography-mass spectrometry. Nat. Protoc. 6(10), 1483–1499. https://doi.org/10.1038/nprot.2011.375 (2011).
Välikangas, T., Suomi, T. & Elo, L. L. A systematic evaluation of normalization methods in quantitative label-free proteomics. Brief Bioinform. 19, 1–11 (2018).
Smirnov, A. et al. ADAP-KDB: A spectral knowledgebase for tracking and prioritizing unknown GC-MS spectra in the NIH’s metabolomics data repository. Anal. Chem. 93, 12213–12220 (2021).
Bylesjö, M. et al. OPLS discriminant analysis: Combining the strengths of PLS-DA and SIMCA classification. J. Chemom. 20, 341–351 (2006).
Eriksson, L. et al. Multi- and Megavariate Data Analysis Basic Principles and Applications (Umetrics Academy, 2013).
Broadhurst, D. et al. Guidelines and considerations for the use of system suitability and quality control samples in mass spectrometry assays applied in untargeted clinical metabolomic studies. Metabolomics 14, 72 (2018).
Rothman, K. J. No adjustments are needed for multiple comparisons. Epidemiology 1, 43–46 (1990).
Bender, R. & Lange, S. Adjusting for multiple testing—When and how?. J. Clin. Epidemiol. 54, 343–349 (2001).
Xi, D. & Tamhane, A. C. A general multistage procedure for k-out-of-n gatekeeping. Stat. Med. 33, 1321–1335 (2014).
Friedman, J., Hastie, T. & Tibshirani, R. Regularization paths for generalized linear models via coordinate descent. J. Stat. Softw. 33, 1–22 (2010).
Tay, J. K., Narasimhan, B. & Hastie, T. Elastic net regularization paths for all generalized linear models. J. Stat. Softw. 106, 1 (2023).
Li, S. et al. Predicting network activity from high throughput metabolomics. PLoS Comput. Biol. 9, e1003123 (2013).
Chong, J., Wishart, D. S. & Xia, J. Using MetaboAnalyst 4.0 for comprehensive and integrative metabolomics data analysis. Curr. Protoc. Bioinformatics 68, e86 (2019).
Pang, Z. et al. MetaboAnalyst 5.0: Narrowing the gap between raw spectra and functional insights. Nucleic Acids Res 49, W388–W396 (2021).
Pang, Z. et al. Using MetaboAnalyst 5.0 for LC-HRMS spectra processing, multi-omics integration and covariate adjustment of global metabolomics data. Nat. Protoc. 17, 1735–1761 (2022).
Qi, L. & Chen, Y. Circulating bile acids as biomarkers for disease diagnosis and prevention. J. Clin. Endocrinol. Metab. 108, 251–270 (2023).
Haeusler, R. A. et al. Increased bile acid synthesis and impaired bile acid transport in human obesity. J. Clin. Endocrinol. Metab. 101, 1935–1944 (2016).
Osuna-Prieto, F. J. et al. Plasma levels of bile acids are related to cardiometabolic risk factors in young adults. J. Clin. Endocrinol. Metab. 107, 715–723 (2022).
Mercer, K. E. et al. Exercise training and diet-induced weight loss increase markers of hepatic bile acid (BA) synthesis and reduce serum total BA concentrations in obese women. Am. J. Physiol. Endocrinol. Metab. 320, E864–E873 (2021).
Maurer, A. et al. Divergence in aerobic capacity impacts bile acid metabolism in young women. J. Appl. Physiol. 1985(129), 768–778 (2020).
Tveter, K. M., Mezhibovsky, E., Wu, Y. & Roopchand, D. E. Bile acid metabolism and signaling: Emerging pharmacological targets of dietary polyphenols. Pharmacol. Ther. 248, 108457 (2023).
Byrd, D. A. et al. An investigation of cross-sectional associations of a priori-selected dietary components with circulating bile acids. Am. J. Clin. Nutr. 114, 1802–1813 (2021).
Kelly, R. S., Kelly, M. P. & Kelly, P. Metabolomics, physical activity, exercise and health: A review of the current evidence. Biochim. Biophys. Acta Mol. Basis Dis. 1866, 165936 (2020).
Niu, Y.-C. et al. Histidine and arginine are associated with inflammation and oxidative stress in obese women. Br. J. Nutr. 108, 57–61 (2012).
Maltais-Payette, I. et al. Circulating glutamate concentration as a biomarker of visceral obesity and associated metabolic alterations. Nutr. Metab. 15, 78 (2018).
DiNicolantonio, J. J., McCarty, M. F. & OKeefe, J. H. Role of dietary histidine in the prevention of obesity and metabolic syndrome. Open Heart 5, e000676 (2018).
Quesada-Vázquez, S. et al. Potential therapeutic implications of histidine catabolism by the gut microbiota in NAFLD patients with morbid obesity. Cell Rep. Med. 4, 101341 (2023).
Yao, H., Li, K., Wei, J., Lin, Y. & Liu, Y. The contradictory role of branched-chain amino acids in lifespan and insulin resistance. Front. Nutr. 10, 1189982 (2023).
Driuchina, A. et al. Identification of gut microbial lysine and histidine degradation and cyp-dependent metabolites as biomarkers of fatty liver disease. mBio 14, e0266322 (2023).
Maas, M. N., Hintzen, J. C. J., Porzberg, M. R. B. & Mecinović, J. Trimethyllysine: From carnitine biosynthesis to epigenetics. Int. J. Mol. Sci. 21, 9451 (2020).
Zhang, X. et al. Modulating a prebiotic food source influences inflammation and immune-regulating gut microbes and metabolites: insights from the BE GONE trial. EBioMedicine 98, 104873 (2023).
Wang, C. et al. Pipecolic acid confers systemic immunity by regulating free radicals. Sci. Adv. 4, eaar4509 (2018).
Deng, Y. et al. An adipo-biliary-uridine axis that regulates energy homeostasis. Science 355, eaaf5375 (2017).
Kim, M. J. et al. Metabolomics associated with genome-wide association study related to the basal metabolic rate in overweight/obese Korean women. J. Med. Food 22, 499–507 (2019).
Liu, Y. et al. Uridine attenuates obesity, ameliorates hepatic lipid accumulation and modifies the gut microbiota composition in mice fed with a high-fat diet. Food Funct. 12, 1829–1840 (2021).
He, M. et al. Causal relationship between human blood metabolites and risk of ischemic stroke: A Mendelian randomization study. Front. Genet. 15, 1333454 (2024).
Jiang, N. & Zhao, Z. Intestinal aging is alleviated by uridine via regulating inflammation and oxidative stress in vivo and in vitro. Cell Cycle 21, 1519–1531 (2022).
Abiri, B. et al. Association of vitamin D levels with anthropometric and adiposity indicators across all age groups: A systematic review of epidemiologic studies. Endocr. Connect. 13, e230394 (2024).
Vranić, L., Mikolašević, I. & Milić, S. Vitamin D deficiency: Consequence or cause of obesity?. Medicina 55, 541 (2019).
Park, J. E., Pichiah, P. B. T. & Cha, Y.-S. Vitamin D and metabolic diseases: Growing roles of vitamin D. J. Obes. Metab. Syndr. 27, 223–232 (2018).
Wamberg, L., Pedersen, S. B., Rejnmark, L. & Richelsen, B. Causes of vitamin D deficiency and effect of vitamin D supplementation on metabolic complications in obesity: A review. Curr. Obes. Rep. 4, 429–440 (2015).
Deriš, H. et al. Susceptibility of human plasma N-glycome to low-calorie and different weight-maintenance diets. Int. J. Mol. Sci. 23, 15772 (2022).
Greto, V. L. et al. Extensive weight loss reduces glycan age by altering IgG N-glycosylation. Int. J. Obes. 45, 1521–1531 (2021).
Noel, M. et al. the inflammation biomarker GlycA reflects plasma N-Glycan branching. Clin. Chem. 69, 80–87 (2023).
Zhang, L. et al. Functional metabolomics characterizes a key role for N-Acetylneuraminic acid in coronary artery diseases. Circulation 137, 1374–1390 (2018).
Ferrannini, E. et al. Mannose is an insulin-regulated metabolite reflecting whole-body insulin sensitivity in man. Metabolism 102, 153974 (2020).
Mardinoglu, A. et al. Plasma mannose levels are associated with incident type 2 diabetes and cardiovascular disease. Cell Metab. 26, 281–283 (2017).
Yamauchi, M. et al. Urinary level of l-fucose as a marker of alcoholic liver disease. Alcohol Clin. Exp. Res. 17, 268–271 (1993).
Sakai, T. et al. Rapid, simple enzymatic assay of free l-fucose in serum and urine, and its use as a marker for cancer, cirrhosis, and gastric ulcers. Clin. Chem. 36, 474–476 (1990).
Htun, K. T. et al. Identification of metabolic phenotypes in young adults with obesity by 1H NMR metabolomics of blood serum. Life 11, 574 (2021).
Rios, S. et al. Plasma metabolite profiles associated with the World Cancer Research Fund/American Institute for Cancer Research lifestyle score and future risk of cardiovascular disease and type 2 diabetes. Cardiovasc. Diabetol. 22, 252 (2023).
Wei, Y.-H., Ma, X., Zhao, J.-C., Wang, X.-Q. & Gao, C.-Q. Succinate metabolism and its regulation of host–microbe interactions. Gut Microbes 15, 2190300 (2023).
Lee, Y.-M., Shin, J.-Y., Kim, S.-A., Jacobs, D. R. & Lee, D.-H. Can habitual exercise help reduce serum concentrations of lipophilic chemical mixtures? Association between physical activity and persistent organic pollutants. Diabetes Metab. J. 44, 764–774 (2020).
Pelletier, C., Després, J.-P. & Tremblay, A. Plasma organochlorine concentrations in endurance athletes and obese individuals. Med. Sci. Sports Exerc. 34, 1971–1975 (2002).
Huang, Y. & Fang, M. Nutritional and environmental contaminant exposure: A tale of two co-existing factors for disease risks. Environ. Sci. Technol. 54, 14793–14796 (2020).
Jujić, A. et al. Antibodies against phosphorylcholine in hospitalized versus non-hospitalized obese subjects. Sci. Rep. 11, 20246 (2021).
Lapenna, D. Glutathione and glutathione-dependent enzymes: From biochemistry to gerontology and successful aging. Ageing Res. Rev. 92, 102066 (2023).
Singh, Y. P. & Kumar, H. Tryptamine: A privileged scaffold for the management of Alzheimer’s disease. Drug Dev. Res. 84, 1578–1594 (2023).
Alvarenga, L., Ferreira, M. S., Kemp, J. A. & Mafra, D. The role of betaine in patients with chronic kidney disease: A narrative review. Curr. Nutr. Rep. 11, 395–406 (2022).
Palmnäs, M. et al. Perspective: Metabotyping—a potential personalized nutrition strategy for precision prevention of cardiometabolic disease. Adv. Nutr. 11, 524–532 (2020).